Eva Milkereit

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

J.-M. Lee, E.M. Ramos, J.-H. Lee et al. · Neurology · 2012 · 391 citations · Full text

Life Sciences, Genetics, Neurology +15

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Davina J. Hensman Moss, Antonio F. Pardiñas, Douglas R. Langbehn et al. · The Lancet Neurology · 2017 · 332 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Do Normal D-dimer Levels Reliably Exclude Cerebral Sinus Thrombosis?

Christoph M. Kosinski, Michael Mull, Michael Schwarz et al. · Stroke · 2004 · 123 citations · Full text

Medicine, Neurology, Radiology +16

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease

Johannes Schiefer, G. Bernhard Landwehrmeyer, Hans‐Gerd Lüesse et al. · Movement Disorders · 2002 · 116 citations

Life Sciences, Neurology, Neuroscience +17

The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease

Johannes Schiefer, Arne Sprünken, Christiane Puls et al. · Brain Research · 2004 · 105 citations

Life Sciences, Neuroscience, Pharmacology +16